Search by Drug Name or NDC
NDC 52427-0667-30 LOREEV XR 3 mg/1 Details
LOREEV XR 3 mg/1
LOREEV XR is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Almatica Pharma LLC. The primary component is LORAZEPAM.
MedlinePlus Drug Summary
Lorazepam is used to relieve anxiety. Lorazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow for relaxation.
Related Packages: 52427-0667-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lorazepam
Product Information
| NDC | 52427-0667 |
|---|---|
| Product ID | 52427-667_f57da925-46cd-fc83-7cd1-f6f508849740 |
| Associated GPIs | 5710006000F330 |
| GCN Sequence Number | 082633 |
| GCN Sequence Number Description | lorazepam CAP ER 24H 3 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 50781 |
| HICL Sequence Number | 004846 |
| HICL Sequence Number Description | LORAZEPAM |
| Brand/Generic | Brand |
| Proprietary Name | LOREEV XR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lorazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/1 |
| Substance Name | LORAZEPAM |
| Labeler Name | Almatica Pharma LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA214826 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 52427-0667-30 (52427066730)
| NDC Package Code | 52427-667-30 |
|---|---|
| Billing NDC | 52427066730 |
| Package | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52427-667-30) |
| Marketing Start Date | 2021-09-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |